CH5132799

· Chugai Pharma Europe Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CH5132799, covering 2014-06-23 to 2014-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors [Phase 1]